Valuation : Electromed, Inc.

Market Cap 236M 204M 192M 175M 327M 22.32B 329M 2.27B 882M 11.41B 887M 868M 37.48B P/E 2027 *
19.4x
P/E 2028 * 16.7x
Enterprise Value 236M 204M 192M 175M 327M 22.32B 329M 2.27B 882M 11.41B 887M 868M 37.48B EV / Sales 2027 *
2.84x
EV / Sales 2028 * 2.57x
Free-Float
83%
Yield 2027 *
-
Yield 2028 * -
1 day+4.21%
1 week-11.11%
Current month+0.97%
1 month-30.67%
3 months-22.80%
6 months+17.18%
Current year-3.02%
1 week 26.89
Extreme 26.89
30.66
1 month 26.89
Extreme 26.89
43.74
Current year 23.01
Extreme 23.01
47.4
1 year 23.01
Extreme 23.01
47.4
3 years 9.53
Extreme 9.53
47.4
5 years 8.75
Extreme 8.75
47.4
10 years 3.38
Extreme 3.38
47.4
Manager TitleAgeSince
Chief Executive Officer 61 01/07/2023
Director of Finance/CFO 44 14/11/2022
Compliance Officer - 01/09/2023
Director TitleAgeSince
Chairman 69 01/07/2023
Director/Board Member 76 21/11/2014
Director/Board Member 57 15/08/2019
Date Insider Type Main position Quantity % Market Cap. Importance
30/6/26 Tax

Chief Financial Officer

-674 0.0081%
4/6/26 Exercice

Chief Financial Officer

31,003 0.3744%
15/5/26 Exercice

Chairman

120,000 1.4501%
Change 5-day change 1-year change 3-year change Capi.($)
+4.21%-11.11%+17.91%+181.27% 236M
+1.34%-3.97%+24.82%+9.21% 225B
+1.44%-2.53%+3.00%-20.96% 148B
+0.71%+0.39%-20.72%+19.80% 131B
+0.60%+0.42%-54.65%-9.79% 70.1B
+0.09%+0.04%+11.07%+18.91% 52.35B
+0.08%+0.61%-15.43%-13.41% 50.91B
+0.97%-2.38%+20.91%+24.18% 42.68B
+1.57%-0.48%+39.03%+46.68% 40.5B
-0.21%-2.05%-14.80%+45.03% 33.3B
Average +1.04%-2.50%+1.11%+30.09% 79.4B
Weighted average by Cap. +0.92%-2.12%+1.58%+7.14%

Financials

2027 *2028 *
Net sales 83.15M 71.73M 67.57M 61.57M 115M 7.85B 116M 800M 310M 4.02B 312M 305M 13.19B 92.05M 79.41M 74.81M 68.16M 127M 8.7B 128M 886M 344M 4.45B 346M 338M 14.6B
Net income 12.6M 10.87M 10.24M 9.33M 17.44M 1.19B 17.57M 121M 47.05M 609M 47.31M 46.28M 2B 14.75M 12.72M 11.99M 10.92M 20.41M 1.39B 20.57M 142M 55.08M 712M 55.39M 54.18M 2.34B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
196
Date Price Change Volume
02/09/26 USD 28.24 +4.21% 119,125
01/09/26 USD 27.10 -3.11% 167,957
31/08/26 USD 27.97 -5.51% 181,626
28/08/26 USD 29.60 -1.79% 179,740
27/08/26 USD 30.14 -5.13% 177,584
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
28.24USD
Average target price
48.50USD
Spread / Average Target
+71.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock